1. Bousquet J, Schünemann HJ, Zuberbier T, et al. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy. 2010;65:1212-1221.
2. Bousquet J, Van-Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(suppl):S147-S334.
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63(suppl 86):S8-S160.
4. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466-476.
5. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38:19-42.
6. Walker SM, Durham SR, Till SJ, et al. Immunotherapy for allergic rhinitis. Clin Exp Allergy. 2011;41:1177-1200.
7. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, et al. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2007;(1):CD003163.-
8. Nasser M, Fedorowicz, Alijufairi H, et al. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2010;(7):CD006989.-
9. Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007;(1):CD001936.-
10. Wilson D, Torres-Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2003;(2):CD002893.-
11. Sheikh A, Hurwitz B, Nurmatov U, et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2010;(7):CD001563.-
12. Nurmatov U, van Schayck CP, Hurwitz B, et al. House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review. Allergy. 2012;67:158-165.
13. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(suppl):S2-S8.
14. Nathan RA. The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis. Clin Ther. 2008;30:573-586.
15. Kemp AS. Allergic rhinitis. Paediatric Respir Rev. 2009;10:63-68.
16. Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010;81:1440-1446.
17. Hong J, Bielory B, Rosenberg JL, et al. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: a systematic review. Allergy Asthma Proc. 2011;32:22-35.
18. Hu W, Katelaris CH, Kemp AS. Allergic rhinitis – practical management strategies. Aust Fam Physician. 2008;37:214-220.
19. Veramyst (fluticasone furoate) nasal spray [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; August 2012. Available at: http://us.gsk.com/products/assets/us_veramyst.pdf. Accessed January 16, 2013.
20. Nasacort AQ (triamcinolone acetonide) nasal spray [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2010. Available at: http://products.sanofi.us/nasacort_aq/nasacort_aq.html. Accessed January 16, 2013.
21. Rhinocort AQUA 32 mcg (budesonide) nasal spray [prescribing information]. Wilmington, Del: AstraZeneca; revised December 2010. Available at: http://www1.astrazeneca-us.com/pi/Rhinocort_Aqua.pdf. Accessed January 16, 2013.
22. Astelin (azelastine hydrochloride) spray, metered [prescribing information]. Somerset, NJ: Meda Pharmaceuticals; revised July 2011. Available at: http://www.astelin.com/pdf/astelin_pi.pdf. Accessed January 16, 2013.
23. Patanase (olopatadine hydrochloride) nasal spray [prescribing information]. Fort Worth, Tex: Alcon Laboratories; revised February 2012. Available at: http://ecatalog.alcon.com/PI/Patanase_us_en.pdf. Accessed January 16, 2013.
24. Xyzal (levocetirizine dihydrochloride) tablets and oral solution [prescribing information]. Smyrna, Ga: UCB and Bridgewater, NJ: sanofi-aventis; 2010. Available at: http://products.sanofi.us/xyzal/xyzal.pdf. Accessed January 16, 2013.
25. Allegra (fexofenadine hydrochloride) tablets, ODT, and oral suspension [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2007. Available at: http://products.sanofi.us/allegra/allegra.html. Accessed January 16, 2013.
26. Singulair (montelukast sodium) tablets, chewable tablets, and oral granules [prescribing information]. Whitehouse Station, NJ: Merck; revised November 2012. Available at: http://www.merck.com/product/usa/pi_circulars/s/singulair/singulair_pi.pdf. Accessed January 16, 2013.
27. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol. 2011;106(suppl):S12-S16.
28. Lim MY, Leong JM. Allergic rhinitis: evidence-based practice. Singapore Med J. 2010;51:542-550.
29. Angier E, Willington J, Scadding G, et al. Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline. Prim Care Respir J. 2010;19:217-222.
30. Radulovic S, Wilson D, Calderon M, et al. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011;66:740-752.
31. Matricardi PM, Kuna P, Panetta V, et al. Subcutaneous immunotherapy and pharmacology in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011;128:791-799.
32. Lee MS, Pittler MH, Shin B, et al. Acupuncture for allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2009;102:269-279.
33. Roberts J, Huissoon A, Dretzke J, et al. A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis. BMC Complement Altern Med. 2008;8:13.-
34. Zhang CS, Yang AW, Zhang AL, et al. Ear-acupressure for allergic rhinitis: a systematic review. Clin Otolaryngol. 2010;35:6-12.
35. Vliagoftis H, Kouranos VD, Betsi GI, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101:570-579.
CORRESPONDENCE Suzanne Minor, MD, Florida International University Herbert Wertheim College of Medicine; 11200 SW 8th Street, AHC II 361A, Miami, FL 33199; seminor@fiu.edu